Kristin R. Swanson

Kristin R. Swanson

Auto-generated profile, based on publicly available information

Kristin R. Swanson

Mayo Clinic

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
KSKristin R. Swanson
Kristin R. Swanson
CBCarly Bridge
Carly Bridge
JMJ.D. Murray
J.D. Murray
EAEllsworth C. Alvord
Ellsworth C. Alvord

1 October 2000 in Cell Proliferation
Verified
Journal Article
Closed access
KSK. R. Swanson
K. R. Swanson
EAE. C. Alvord
E. C. Alvord
JMJ. D. Murray
J. D. Murray

24 March 2003 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
EMEmmanuel Mandonnet
Emmanuel Mandonnet
JDJean‐Yves Delattre
Jean‐Yves Delattre
MTMarie‐Laure Tanguy
Marie‐Laure Tanguy
KSKristin R. Swanson
Kristin R. Swanson
ACAntoine F. Carpentier
Antoine F. Carpentier
LCLaurent Capelle
Laurent Capelle

1 January 2007 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
PDF file
HHHana L.P. Harpold
Hana L.P. Harpold
EAEllsworth C. Alvord
Ellsworth C. Alvord
KSKristin R. Swanson
Kristin R. Swanson
Gliomas are well known for their potential for aggressive proliferation as well as their diffuse invasion of the normal-appearing parenchyma peripheral to the bulk lesion. This review presents a history of the use of mathematical modeling in the study of the proliferative-invasive growth of gliomas, illustrating the progress made in understanding the in vivo dynamics of invasion and proliferation of tumor cells. Mathematical modeling is based on a sequence of observation, speculation, development of hypotheses to be tested, and comparisons between theory and reality. These mathematical investigations, iteratively compared with experimental and clinical work, demonstrate the essential relationship between experimental and theoretical approaches. Together, these efforts have extended our knowledge and insight into in vivo brain tumor growth dynamics that should enhance current diagnoses and treatments.

2 January 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
WYWei Yang
Wei Yang
NWNicole M. Warrington
Nicole M. Warrington
STSara J. Taylor
Sara J. Taylor
PWPaula Whitmire
Paula Whitmire
ECEduardo Carrasco
Eduardo Carrasco
JRJoshua B. Rubin
Joshua B. Rubin
Male and female glioblastomas are biologically distinct, and improving outcomes may require sex-specific approaches to treatment.

4 December 2007 in British Journal of Cancer
Verified
Journal Article
Open access
KSK R Swanson
K R Swanson
RRRobert C. Rostomily
Robert C. Rostomily
EAE C Alvord
E C Alvord
The prediction of the outcome of individual patients with glioblastoma would be of great significance for monitoring responses to therapy. We hypothesise that, although a large number of genetic-metabolic abnormalities occur upstream, there are two ‘final common pathways’ dominating glioblastoma growth – net rates of proliferation (ρ) and dispersal (D). These rates can be estimated from features of pretreatment MR images and can be applied in a mathematical model to predict tumour growth, impact of extent of tumour resection and patient survival. Only the pre-operative gadolinium-enhanced T1-weighted (T1-Gd) and T2-weighted (T2) volume data from 70 patients with previously untreated glioblastoma were used to derive a ratio D/ρ for each patient. We developed a ‘virtual control’ for each patient with the same size tumour at the time of diagnosis, the same ratio of net invasion to proliferation (D/ρ) and the same extent of resection. The median durations of survival and the shapes of the survival curves of actual and ‘virtual’ patients subjected to biopsy or subtotal resection (STR) superimpose exactly. For those actually receiving gross total resection (GTR), as shown by post-operative CT, the actual survival curve lies between the ‘virtual’ results predicted for 100 and 125% resection of the T1-Gd volume. The concordance between predicted (virtual) and actual survivals suggests that the mathematical model is realistic enough to allow precise definition of the effectiveness of individualised treatments and their site(s) of action on proliferation (ρ) and/or dispersal (D) of the tumour cells without knowledge of any other clinical or pathological information.